Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Cell Death Differ ; 18(5): 769-82, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21113145

RESUMO

Loss of parkin function is responsible for the majority of autosomal recessive parkinsonism. Here, we show that parkin is not only a stress-protective, but also a stress-inducible protein. Both mitochondrial and endoplasmic reticulum (ER) stress induce an increase in parkin-specific mRNA and protein levels. The stress-induced upregulation of parkin is mediated by ATF4, a transcription factor of the unfolded protein response (UPR) that binds to a specific CREB/ATF site within the parkin promoter. Interestingly, c-Jun can bind to the same site, but acts as a transcriptional repressor of parkin gene expression. We also present evidence that mitochondrial damage can induce ER stress, leading to the activation of the UPR, and thereby to an upregulation of parkin expression. Vice versa, ER stress results in mitochondrial damage, which can be prevented by parkin. Notably, the activity of parkin to protect cells from stress-induced cell death is independent of the proteasome, indicating that proteasomal degradation of parkin substrates cannot explain the cytoprotective activity of parkin. Our study supports the notion that parkin has a role in the interorganellar crosstalk between the ER and mitochondria to promote cell survival under stress, suggesting that both ER and mitochondrial stress can contribute to the pathogenesis of Parkinson's disease.


Assuntos
Fator 4 Ativador da Transcrição/metabolismo , Retículo Endoplasmático/fisiologia , Mitocôndrias/fisiologia , Estresse Fisiológico , Ubiquitina-Proteína Ligases/genética , Sequência de Bases , Carbonil Cianeto m-Clorofenil Hidrazona/farmacologia , Morte Celular , Linhagem Celular , Retículo Endoplasmático/efeitos dos fármacos , Inibidores Enzimáticos/efeitos adversos , Genes Reporter , Humanos , Ionóforos/farmacologia , Luciferases de Renilla/biossíntese , Potencial da Membrana Mitocondrial , Mitocôndrias/efeitos dos fármacos , Regiões Promotoras Genéticas , Complexo de Endopeptidases do Proteassoma/fisiologia , Proteínas Proto-Oncogênicas c-jun/metabolismo , Interferência de RNA , Elementos de Resposta/genética , Transdução de Sinais , Tapsigargina/efeitos adversos , Transcrição Gênica , Ubiquitina-Proteína Ligases/metabolismo , Resposta a Proteínas não Dobradas , Regulação para Cima , eIF-2 Quinase/metabolismo
2.
Hum Mol Genet ; 19(19): 3734-46, 2010 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-20639397

RESUMO

Growing evidence highlights a role for mitochondrial dysfunction and oxidative stress as underlying contributors to Parkinson's disease (PD) pathogenesis. DJ-1 (PARK7) is a recently identified recessive familial PD gene. Its loss leads to increased susceptibility of neurons to oxidative stress and death. However, its mechanism of action is not fully understood. Presently, we report that DJ-1 deficiency in cell lines, cultured neurons, mouse brain and lymphoblast cells derived from DJ-1 patients display aberrant mitochondrial morphology. We also show that these DJ-1-dependent mitochondrial defects contribute to oxidative stress-induced sensitivity to cell death since reversal of this fragmented mitochondrial phenotype abrogates neuronal cell death. Reactive oxygen species (ROS) appear to play a critical role in the observed defects, as ROS scavengers rescue the phenotype and mitochondria isolated from DJ-1 deficient animals produce more ROS compared with control. Importantly, the aberrant mitochondrial phenotype can be rescued by the expression of Pink1 and Parkin, two PD-linked genes involved in regulating mitochondrial dynamics and quality control. Finally, we show that DJ-1 deficiency leads to altered autophagy in murine and human cells. Our findings define a mechanism by which the DJ-1-dependent mitochondrial defects contribute to the increased sensitivity to oxidative stress-induced cell death that has been previously reported.


Assuntos
Peptídeos e Proteínas de Sinalização Intracelular/deficiência , Peptídeos e Proteínas de Sinalização Intracelular/genética , Mitocôndrias/genética , Mitocôndrias/patologia , Proteínas Oncogênicas/deficiência , Proteínas Oncogênicas/genética , Doença de Parkinson/genética , Acetilcisteína/farmacologia , Animais , Autofagia/efeitos dos fármacos , Encéfalo/metabolismo , Encéfalo/patologia , Morte Celular/efeitos dos fármacos , Linhagem Celular , Humanos , Camundongos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/ultraestrutura , Proteínas Mutantes/metabolismo , Neostriado/efeitos dos fármacos , Neostriado/metabolismo , Neostriado/patologia , Neostriado/ultraestrutura , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Neurônios/patologia , Neurônios/ultraestrutura , Doença de Parkinson/patologia , Peroxirredoxinas , Fenótipo , Proteína Desglicase DJ-1 , Proteínas Quinases/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Ubiquitina-Proteína Ligases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA